https://www.macrotrends.net/stocks/charts/AVXL/anavex-life-sciences/stock-splits
Anavex Life Sciences - 15 Year Stock Split History | AVXL | MacroTrends
Stock split history for Anavex Life Sciences since 2011. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please...
stock split historylife sciencesanavexyearmacrotrends
https://www.biospace.com/anavex-confirms-positive-preclinical-epilepsy-data-for-anavex-2-73-validation-as-potential-platform-drug-for-multiple-neurodegenerative-diseases
Anavex Confirms Positive Preclinical Epilepsy Data For ANAVEX 2-73 - Validation As Potential...
https://investingnews.com/anavex-life-sciences-presents-new-data-from-its-ad-004-phase-iib-iii-trial-at-ad-pd-2026-conference-demonstrating-consistent-correlation-between-the-treatment-effect-of-oral-blarcamesine-and-preservat/
Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference...
Mar 23, 2026 - New data show brain-volume preservation correlates with patient outcomes Long-term clinical data indicate 77.4 weeks (17.8 months) time saved with oral...
https://investingnews.com/anavex-life-sciences-to-announce-fiscal-2026-first-quarter-financial-results-on-monday-february-9-2026/
Anavex Life Sciences to Announce Fiscal 2026 First Quarter Financial Results on Monday, February 9,...
Feb 3, 2026 - Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments...
https://www.biospace.com/press-releases/anavex-life-sciences-to-participate-at-upcoming-healthcare-conferences
Anavex Life Sciences to Participate at Upcoming Healthcare Conferences - BioSpace
life sciencesto participatehealthcare conferencesanavexupcoming
https://www.fool.com/investing/2022/12/02/why-anavex-life-sciences-stock-is-surging-today/
Why Anavex Life Sciences Stock Is Surging Today | The Motley Fool
Dec 2, 2022 - The biotech reported positive results from a phase 2b/3 study of its lead Alzheimer's disease candidate.
life sciencesthe motleyanavexstock
https://finviz.com/news/342717/anavex-life-sciences-to-present-at-the-25th-annual-needham-virtual-healthcare-conference
Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference
Stock screener for investors and traders, financial visualizations.
https://finviz.com/news/337829/anavex-life-sciences-presents-significant-treatment-effects-of-blarcamesine-in-new-advanced-alpha-synuclein-model-of-parkinsons-disease-at-adpd-2026-conference
Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced...
Stock screener for investors and traders, financial visualizations.
life sciences
https://www.prnewswire.com/news-releases/shareholder-action-alert-the-schall-law-firm-encourages-investors-in-anavex-life-sciences-corp-with-losses-of-100-000-to-contact-the-firm-302125468.html
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp....
/PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Anavex Life Sciences...
https://www.biospace.com/tricon-alzheimer-s-drug-saw-80-percent-reversal-in-memory-loss-say-anavex-ceo
TRICON: Alzheimer's Drug Saw 80% Reversal in Memory Loss, Say Anavex CEO - BioSpace
https://www.biospace.com/anavex-life-sciences-to-announce-fiscal-2023-third-quarter-financial-results-on-tuesday-august-8-2023webcast-and-conference-call-to-be-held-tuesday-august-8-2023-8-30-am-et
Anavex Life Sciences to Announce Fiscal 2023 Third Quarter Financial Results on Tuesday August 8,...
Aug 1, 2023 - Anavex Life Sciences Corp. today announced that it will issue financial results for its quarter ended June 30, 2023, on Tuesday August 8, 2023.
https://investingnews.com/anavex-life-sciences-reports-fiscal-2026-first-quarter-financial-results-and-provides-business-update/
Anavex Life Sciences Reports Fiscal 2026 First Quarter Financial Results and Provides Business...
Feb 9, 2026 - Company to host a webcast today at 8:30 am Eastern Time Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage...
https://www.sofi.com/invest/stock/AVXL/
Buy Anavex Life Sciences Stock - AVXL Stock Price, Quote & News | SoFi
See real time price charts for AVXL stock, historical data, and recent news. Buy AVXL stock online with no commission fees.
life sciencesprice quotebuyanavexstock
https://www.foxbusiness.com/markets/anavex-stock-jumps-after-company-says-biogen-will-test-lead-drug-candidate
Anavex Stock Jumps After Company Says Biogen Will Test Lead Drug Candidate | Fox Business
Anavex Life Sciences Corp. shares rose 37.7% in morning trade Wednesday to $4.35 per share after the biotech said it signed an agreement with Biogen Inc. to...
https://www.biospace.com/anavex-life-sciences-corp-reports-fiscal-first-quarter-2015-financial-results
Anavex Life Sciences Corp. Reports Fiscal First Quarter 2015 Financial Results - BioSpace
life sciences
https://investingnews.com/anavex-life-sciences-to-present-at-the-46th-td-cowen-annual-health-care-conference/
Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference | INN
Feb 25, 2026 - Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments...
https://investingnews.com/anavex-life-sciences-to-present-at-the-25th-annual-needham-virtual-healthcare-conference/
Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference | INN
Apr 7, 2026 - Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments...
https://investorplace.com/stock-quotes/avxl-stock-quote/
Anavex Life Scie (AVXL) Latest News & Price | InvestorPlace
Check out our AVXL stock analysis, current AVXL quote, charts, and historical prices for Anavex Life Scie stock
latest newsanavexlifescieprice
https://www.benzinga.com/quote/AVXL/short-interest
Anavex Life Sciences Stock Short Interest Report | NASDAQ:AVXL | Benzinga
Short interest for Anavex Life Sciences gives investors a sense of the degree to which investors are betting on the decline of Anavex Life Sciences's stock....
life sciencesshort interestanavexstockreport
https://www.home.saxo/pl-pl/markets/stocks/avxl-xnas
Anavex Life Sciences Corp. akcja | Saxo Bank
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision...
life sciencesanavexcorpakcjasaxo
https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-atara-biotherapeutics-anavex-life-sciences-boxlight-corp-fuelcell-energy-or-upwork-inc-301063628.html
Thinking about buying stock in Atara Biotherapeutics, Anavex Life Sciences, Boxlight Corp, FuelCell...
/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ATRA, AVXL, BOXL, FCEL, and UPWK. To see how InvestorsObserver's proprietary scoring...
https://investingnews.com/anavex-life-sciences-provides-update-on-regulatory-review-in-the-eu-for-blarcamesine-to-treat-early-alzheimer-s-disease-2676617991/
Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early...
Mar 25, 2026 - Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments...
https://anavex.com/
Anavex Life Sciences | Advancing Therapies for Alzheimer’s and Parkinson's Disease
May 13, 2026 - Anavex Life Sciences (Nasdaq: AVXL) is a biopharmaceutical leader advancing targeted CNS therapies through innovative therapeutic discovery and development.
life sciencesanavexadvancingtherapies
https://www.annualreports.com/Company/anavex-life-sciences-corp
Anavex Life Sciences Corp. - AnnualReports.com
life sciencesanavexcorp
https://www.prnewswire.com/news-releases/class-action-filed-against-anavex-life-sciences-corporation-avxl-seeking-recovery-for-investors--contact-levi--korsinsky-302106633.html
Class Action Filed Against Anavex Life Sciences Corporation (AVXL) Seeking Recovery for Investors -...
https://www.home.saxo/fr-be/markets/stocks/avxl-xnas
Anavex Life Sciences Corp. action | Saxo Bank
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision...
life sciencesanavexcorpactionsaxo
https://investingnews.com/anavex-life-sciences-to-present-at-the-citizens-life-sciences-conference/
Anavex Life Sciences to Present at the Citizens Life Sciences Conference | INN
Mar 3, 2026 - Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments...
life sciencesat theanavexpresentcitizens
https://investingnews.com/anavex-life-sciences-to-present-at-the-25th-annual-needham-virtual-healthcare-conference-2676674292/
Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference | INN
Apr 7, 2026 - Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments...
https://www.home.saxo/markets/stocks/avxl-xnas
Anavex Life Sciences Corp. stock | Saxo
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision...
life sciencesanavexcorpstocksaxo
https://finviz.com/news/340739/anavex-life-sciences-provides-comprehensive-regulatory-update
Anavex Life Sciences Provides Comprehensive Regulatory Update
Stock screener for investors and traders, financial visualizations.
life sciencesanavexprovidescomprehensiveregulatory
https://finviz.com/quote?t=AVXL&ty=tr&ta=1&p=d
AVXL - Anavex Life Sciences Corp Website Traffic and Mobile Apps Usage
AVXL - Anavex Life Sciences Corp - Stock screener for investors and traders, financial visualizations.
life sciencescorp websitemobile appsanavex
https://investingnews.com/anavex-life-sciences-provides-comprehensive-regulatory-update/
Anavex Life Sciences Provides Comprehensive Regulatory Update | INN
Mar 30, 2026 - Dialogue continues with European Medicines Agency (EMA) to advance the development program of oral blarcamesine in early Alzheimer's disease Additional data...
life sciencesregulatory updateanavexprovidescomprehensive